Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Travere Therapeutics, Inc. (NASDAQ: TVTX) breached their fiduciary duties to shareholders ...
Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the launch of a new awareness campaign, “Play It Forward,” to bring hope and encouragement to the focal segmental ...
Investor's Business Daily on MSN
This stock of the day rides big pharma royalties; it's up 56% in 2026
LGND stock has risen more than 56.5% so far in 2026. Ligand doesn't make drugs; it forks over funding in exchange for Big ...
In a report released today, Vamil Divan from Guggenheim maintained a Buy rating on Insmed, with a price target of $207.00. Claim 55% Off TipRanks. Unlock powerful investing tools ...
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm ...
Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes ...
With its focus on small-cap companies and exposure to China, The Biotech Growth Trust (BIOG) is one such example. Over the past year, the trust’s total shareholder return was 105 per cent – double the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results